4//SEC Filing
BRIDGE STREET FUND 1995 LP 4
Accession 0000769993-03-000591
CIK 0001013243other
Filed
Oct 26, 7:00 PM ET
Accepted
Oct 27, 8:58 PM ET
Size
22.8 KB
Accession
0000769993-03-000591
Insider Transaction Report
Form 4
AAIPHARMA INCAAII
GOLDMAN SACHS GROUP INC
10% Owner
Transactions
- Purchase
Common Stock
2003-10-23$17.56/sh+5,000$87,800→ 3,420,247 total(indirect: See Footnotes) - Sale
Common Stock
2003-10-23$17.56/sh−5,000$87,800→ 3,415,247 total(indirect: See Footnotes)
GS ADVISORS II LLC
10% Owner
Transactions
- Sale
Common Stock
2003-10-23$17.56/sh−5,000$87,800→ 3,415,247 total(indirect: See Footnotes) - Purchase
Common Stock
2003-10-23$17.56/sh+5,000$87,800→ 3,420,247 total(indirect: See Footnotes)
GS CAPITAL PARTNERS II L P
10% Owner
Transactions
- Purchase
Common Stock
2003-10-23$17.56/sh+5,000$87,800→ 3,420,247 total(indirect: See Footnotes) - Sale
Common Stock
2003-10-23$17.56/sh−5,000$87,800→ 3,415,247 total(indirect: See Footnotes)
GOLDMAN SACHS & CO
10% Owner
Transactions
- Purchase
Common Stock
2003-10-23$17.56/sh+5,000$87,800→ 3,420,247 total(indirect: See Footnotes) - Sale
Common Stock
2003-10-23$17.56/sh−5,000$87,800→ 3,415,247 total(indirect: See Footnotes)
GOLDMAN SACHS & CO OHG
10% Owner
Transactions
- Sale
Common Stock
2003-10-23$17.56/sh−5,000$87,800→ 3,415,247 total(indirect: See Footnotes) - Purchase
Common Stock
2003-10-23$17.56/sh+5,000$87,800→ 3,420,247 total(indirect: See Footnotes)
GS ADVISORS LLC
10% Owner
Transactions
- Purchase
Common Stock
2003-10-23$17.56/sh+5,000$87,800→ 3,420,247 total(indirect: See Footnotes) - Sale
Common Stock
2003-10-23$17.56/sh−5,000$87,800→ 3,415,247 total(indirect: See Footnotes)
GS CAPITAL PARTNERS II GERMANY CLP
10% Owner
Transactions
- Purchase
Common Stock
2003-10-23$17.56/sh+5,000$87,800→ 3,420,247 total(indirect: See Footnotes) - Sale
Common Stock
2003-10-23$17.56/sh−5,000$87,800→ 3,415,247 total(indirect: See Footnotes)
BRIDGE STREET FUND 1995 LP
10% Owner
Transactions
- Sale
Common Stock
2003-10-23$17.56/sh−5,000$87,800→ 3,415,247 total(indirect: See Footnotes) - Purchase
Common Stock
2003-10-23$17.56/sh+5,000$87,800→ 3,420,247 total(indirect: See Footnotes)
STONE STREET FUND 1995 LP
10% Owner
Transactions
- Sale
Common Stock
2003-10-23$17.56/sh−5,000$87,800→ 3,415,247 total(indirect: See Footnotes) - Purchase
Common Stock
2003-10-23$17.56/sh+5,000$87,800→ 3,420,247 total(indirect: See Footnotes)
GS CAPITAL PARTNERS II OFFSHORE LP
10% Owner
Transactions
- Purchase
Common Stock
2003-10-23$17.56/sh+5,000$87,800→ 3,420,247 total(indirect: See Footnotes) - Sale
Common Stock
2003-10-23$17.56/sh−5,000$87,800→ 3,415,247 total(indirect: See Footnotes)
Footnotes (6)
- [F1]The positions reported herein have been adjusted to reflect aaiPharma, Inc.'s (the "Company") February 19, 2003 three-for-two common stock split.
- [F2]This statement is being filed by GS Capital Partners II, L.P. (GSCP), GS Capital Partners II Offshore, L.P. (GSCP II Offshore), GS Capital Partners II (Germany) Civil Law Partnership (GSCP II Germany), Stone Street Fund 1995, L.P. (1995 Stone) and Bridge Street Fund 1995, L.P. ("1995 Bridge" and, together with GSCP, GSCP II Offshore, GSCP II Germany and 1995 Stone, the "Limited Partnerships"), Stone Street 1995, L.L.C. (Stone GP), GS Advisors, L.L.C. (GS Advisors), GS Advisors II, L.L.C. (GS Advisors II), Goldman, Sachs & Co. oHG (GS oHG), Goldman, Sachs & Co. (Goldman Sachs), and The Goldman Sachs Group, Inc. ("GS Group" and, together with Goldman Sachs, GS Advisors, GS Advisors II, GS oHG, Stone GP and the Limited Partnerships, the "Reporting Persons"). Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate.
- [F3]The securities reported herein as purchased and sold were purchased and sold and were beneficially owned directly by Goldman Sachs. Without admitting any legal obligation, Goldman Sachs will remit appropriate profits, if any, to the Company. The Reporting Persons other than GS Group and Goldman Sachs disclaim beneficial ownership of the shares of Common Stock beneficially owned directly by Goldman Sachs.
- [F4]Goldman Sachs and GS Group may be deemed to beneficially own indirectly in the aggregate 3,415,247 shares of Common Stock through the Limited Partnerships, of which affiliates of Goldman Sachs and GS Group are the general partner, managing general partner or managing partner. Goldman Sachs is an indirect wholly-owned subsidiary of GS Group. Goldman Sachs is the investment manager of GSCP, GSCP II Offshore, and GSCP II Germany. Goldman Sachs and GS Group each disclaims beneficial ownership of the shares of Common Stock owned by the Limited Partnerships except to the extent of their pecuniary interest therein.
- [F5]GSCP beneficially owns directly and its general partner, GS Advisors, may be deemed to beneficially own indirectly 2,142,823 shares of Common Stock. GSCP II Offshore beneficially owns directly and its general partner, GS Advisors II, may be deemed to beneficially own indirectly 851,862 shares of Common Stock. GSCP II Germany beneficially owns directly and its managing partner, GS oHG, may be deemed to beneficially own indirectly 79,036 shares of Common Stock. 1995 Stone beneficially owns directly and its general partner, Stone GP, may be deemed to beneficially own indirectly 160,698 shares of Common Stock through 1995 Stone. 1995 Bridge beneficially owns directly and its managing general partner, Stone GP, may be deemed to beneficially own indirectly 180,828 shares of Common Stock through 1995 Bridge.
- [F6]Each of GS Advisors, GS Advisors II, GS oHG and Stone GP disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest in such securities.
Documents
Issuer
AAIPHARMA INC
CIK 0001013243
Entity typeother
Related Parties
1- filerCIK 0000941186
Filing Metadata
- Form type
- 4
- Filed
- Oct 26, 7:00 PM ET
- Accepted
- Oct 27, 8:58 PM ET
- Size
- 22.8 KB